Almut Winterstein

54PUBLICATIONS
150CO-AUTHORS
Molecular medicineNanotoxicology, health and safetyClinical pharmacology and therapeuticsEpidemiological methodsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Sep 08, 2026
Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US' Largest Medical Cannabis Program: Cross-Sectional Study.

|Apr 17, 2026
Risk of Fetal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool.

|Mar 26, 2026
Pain and treatment outcomes after initiating methadone vs buprenorphine among medicare patients with opioid use disorder and comorbid chronic pain: A target trial emulation.

Yu-Jung Jenny Wei, Almut G Winterstein, Roger B Fillingim

|Aug 05, 2025
Teratogenic Risk Impact Mitigation (TRIM): Development of Explicit Criteria to Facilitate Decisions Regarding Teratogenic Risk Mitigation Strategies.

Celeste L Y Ewig, Yanning Wang, Nicole E Smolinski

|Apr 22, 2025
Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension.

Shailina Keshwani, Kayla M Smith, Almut G Winterstein

|Apr 03, 2025
Respiratory Syncytial Virus Incidence in Young Children in the United States: Impact of Methodologies and Patient Characteristics.

Sabina O Nduaguba, Phuong T Tran, Renata Shih

Pageof 9

Frequent Collaborators

7 joint publications

Amir Sarayani

7 joint publications

Yu-Jung Jenny Wei

5 joint publications

Sabina O Nduaguba

5 joint publications

Haesuk Park